Roger Dansey
Director/Board Member presso INOVIO PHARMACEUTICALS, INC.
Patrimonio netto: 49 732 $ in data 31/03/2024
Profilo
Attualmente, Roger D. Dansey occupa la posizione di responsabile medico di Seagen Inc. In passato il dottor Dansey ha ricoperto la posizione di vicepresidente della ricerca clinica oncologica presso Gilead Sciences, Inc. e SVP & Head-Therapeutic Area presso Merck Research Laboratories Massachusetts LLC. Il Dr. Dansey ha ricevuto un dottorato dall'Università del Witwatersrand.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
16/11/2023 | 3 583 ( 0.02% ) | 49 732 $ | 31/03/2024 |
Posizioni attive di Roger Dansey
Società | Posizione | Inizio |
---|---|---|
INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 13/05/2021 |
KRONOS BIO, INC. | Director/Board Member | 20/04/2023 |
Precedenti posizioni note di Roger Dansey
Società | Posizione | Fine |
---|---|---|
SEAGEN INC. | Chief Executive Officer | 09/11/2022 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | 01/04/2018 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/04/2018 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2014 |
Formazione di Roger Dansey
University of the Witwatersrand | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
INOVIO PHARMACEUTICALS, INC. | Health Technology |
KRONOS BIO, INC. | Health Technology |
Aziende private | 2 |
---|---|
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
- Borsa valori
- Insiders
- Roger Dansey